Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Authors:
Open Access
Abstract
The cardiovascular and hypokalaemic effects of equal doses of inhaled fenoterol, isoprenaline and salbutamol were compared in eight healthy male volunteers, in a double blind, placebo controlled study. Increasing doses of 400, 600, and 800 micrograms were given from a metered dose inhaler at 15 minute intervals, followed by measurements of heart rate, blood pressure, total electromechanical systole (as a measure of inotropic response), QTc interval, and plasma potassium concentration. After repeated inhalation, fenoterol resulted in significantly greater chronotropic, electrocardiographic, and hypokalaemic effects than either isoprenaline or salbutamol. The maximum inotropic effect of fenoterol was similar to that of isoprenaline.Keywords
This publication has 24 references indexed in Scilit:
- CARDIAC ARRHYTHMIAS CAUSED BY NEBULISED BETA-AGONIST THERAPYThe Lancet, 1987
- Recommendations of the asthma mortality task forceJournal of Allergy and Clinical Immunology, 1987
- HYPOKALAEMIA INDUCED BY INHALATION OF FENOTEROLThe Lancet, 1985
- Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacologyPostgraduate Medical Journal, 1983
- Nebulised salbutamol and angina.BMJ, 1982
- Effects of atropine on diastolic time.Circulation, 1981
- Some statistical methods useful in circulation research.Circulation Research, 1980
- A critical review of the systolic time intervals.Circulation, 1977
- Torsade De Pointes, an atypical ventricular tachycardia.Heart, 1976
- Investigation into use of drugs preceding death from asthma.BMJ, 1968